Biosimilars Generic Medicine Pharmaceutical Companies 
European Pharmaceutical Review
FEBRUARY 26, 2024
Medicine indication extensions recommended by the CHMP The committee recommended extensions of indications for six EU-approved medicines, including: CARVYKTI ® ▼ (ciltacabtagene autoleucel; cilta-cel)* , Keytruda and Reblozyl*. These products were designated as an orphan medicine during their development.
Express Pharma
SEPTEMBER 6, 2023
In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.
Expert insights. Personalized for you.
98 
Let's personalize your content